SCHEMBL4674262

SCHEMBL4674262

COC(=O)COc1cc(C(C)C)c(SC#N)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
BCHE P06276 3/20 0.39
ACHE P22303 3/20 0.39
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP1A2 P05177 2/20 0.36
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
PKM P14618 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
ADRA1B P35368 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4676860 0.87 LMNA (0.46) LMNABCHEACHEKDM4EGAA
SCHEMBL4674073 0.86 LMNA (0.45) LMNAKDM4EPOLBHTTGAA
SCHEMBL4676960 0.84 LMNA (0.43) LMNAKDM4EPOLBHTTGAA
SCHEMBL4677857 0.83 LMNA (0.42) LMNAKDM4EPOLBHTTGAA
SCHEMBL4680278 0.83 LMNA (0.42) LMNAKDM4EPOLBHTTGAA
SCHEMBL4673430 0.83 LMNA (0.56) LMNAKDM4EHTTGAATDP1
SCHEMBL4680002 0.83 HMGCR (0.44) LMNAKDM4EPOLBHTTGAA
SCHEMBL7998684 0.81 LMNA (0.40) LMNAKDM4EPOLBHTTGAA
SCHEMBL4673737 0.81 LMNA (0.40) LMNAKDM4EPOLBHTTGAA
SCHEMBL4677171 0.80 LMNA (0.44) LMNABCHEACHEKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY Warner-Lambert Company LLC (US) 2004-12-08 EP disclosed
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation CHENG XUE-MIN (US) 2003-11-06 US disclosed
WO-2003074050-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER-LAMBERT COMPANY LLC (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation PPARA, PPARD, PPARG LMNA 1479/4885BCHE 1434/4885ACHE 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.